Open access · US-GOV
via ClinicalTrials.gov Clinical trial
Neuroplasticity Enhancement From Cognitive Training Reinforced by Psilocybin (NECTAR) in Aging and Alzheimer's Disease
Authors not listed
National Institute on Aging (NIA) · 2026
Abstract
Background:
Normal aging, as well as dementias such as Alzheimer s disease, can cause changes in the brain that affect memory, attention, and thinking. Researchers want to know if regular mental tasks (cognitive training) can improve brain function in older adults. They also want to know if psilocybin, a compound found in certain mushrooms, can further support improved brain function.
Objective:
To learn how regular cognitive training, with or without psilocybin, can improve brain health in older adults.
Eligibility:
People aged 65 years and older with mild cognitive impairment or early-stage Alzheimer s disease. Healthy older adults with normal cognition are also needed.
Design:
Participants will be screened. They will have a test of their heart function and an imaging scan. They will have mental health screening and tests of their thinking and memory. They will practice brain-training tasks on a tablet.
Participants will be divided into 2 groups: 1 will have cognitive training plus psilocybin; 1 will have cognitive training only.
Those having cognitive training only will have 5 or 6 clinic visits. They will take the tablet home to practice brain training daily. They will wear a device to measure brain waves as they sleep; they may have 1 overnight stay in the clinic, or they may wear the device at home. Imaging scans and other tests will be repeated at each visit.
Those taking psilocybin will have up to 9 clinic visits. In addition to the visits for cognitive training, they will take 1 psilocybin capsule by mouth 2 weeks apart (the second dose is optional). They will remain in the clinic for 24 hours after each dose.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-10-10 MST
Cite this
APA
Anonymous. (2026). Neuroplasticity Enhancement From Cognitive Training Reinforced by Psilocybin (NECTAR) in Aging and Alzheimer's Disease. <em>National Institute on Aging (NIA)</em>. https://clinicaltrials.gov/study/NCT07721467
Vancouver
Anonymous. Neuroplasticity Enhancement From Cognitive Training Reinforced by Psilocybin (NECTAR) in Aging and Alzheimer's Disease. National Institute on Aging (NIA). 2026.
BibTeX
@misc{anon2026Neurop,
title = {Neuroplasticity Enhancement From Cognitive Training Reinforced by Psilocybin (NECTAR) in Aging and Alzheimer's Disease},
author = {Anonymous},
journal = {National Institute on Aging (NIA)},
year = {2026},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
National Institute on Aging (NIA) 2026
Open access · US-GOV
Amyloid PET Imaging in the Baltimore Longitudinal Study of Aging (BLSA)
University of South Florida 2015
Open access · US-GOV
The Impact of Piano Training on Cognitive Performance and Psychosocial Well-Being in Older Adults
University of Illinois at Chicago 2026
Open access · US-GOV
Training the Aging Brain Through Speed: Examining Cerebrovascular Adaptations Associated With Motor-Cognitive Performance Following High-Velocity Resistance Training in Older Adults at Risk for AD/ADRD
National Institute on Aging (NIA) 2014
Open access · US-GOV
The Baltimore Longitudinal Study of Aging (BLSA)
The University of Texas at Dallas 2022
Open access · US-GOV
Mindfulness and Attention Training Intervention to Lower Distractibility in Aging
Bright Cloud International Corp 2022
Open access · US-GOV